Dithranol in an Emulsifying Oil Base (Bio-Wash-Oil) for the Treatment of Psoriasis of the Scalp

On the scalp, dithranol has been studied in only a few trials. The dithranol molecule that contains both hydrophilic and lipophilic centers can be incorporated into detergents and allows easy removal from hair. This property has led to the incorporation of dithranol in an emulsifying oil base (bio-wash-oil). The formulation has been used routinely for more than two decades in East Germany. We reexamined the efficacy and safety of dithranol in bio-wash-oil and compared it to dithranol embedded in crystalline monoglycerides (Micanol®) in patients with psoriasis of the scalp. In a prospective, parallel group study, 64 patients attending a day-care clinic were randomly allocated to 3 treatment groups: (1) dithranol in bio-wash-oil; (2) Micanol® cream, and (3) Micanol® cream in bio-wash-oil. Treatment was carried out for 3 weeks and results assessed using a modified Psoriasis Area and Severity Index score. Dithranol in bio-wash-oil resulted in a reduction in the score of 34% on day 7 and 57% on day 14. This was significantly better than in groups 2 and 3, as were the overall response and patients’ assessment at the end of treatment (p < 0.05). Dithranol in a bio-wash-oil is an effective, well-tolerated and low-priced treatment in psoriasis of the scalp.

[1]  H. Trau,et al.  Treatment of scalp seborrheic dermatitis and psoriasis with an ointment of 40% urea and 1% bifonazole , 2000, International journal of dermatology.

[2]  S. Feldman,et al.  Topical corticosteroid in foam vehicle offers comparable coverage compared with traditional vehicles. , 2000, Journal of the American Academy of Dermatology.

[3]  J. Hannigan,et al.  Betamethasone valerate foam 0.12%: a novel vehicle with enhanced delivery and efficacy , 1999, International journal of dermatology.

[4]  P. C. van de Kerkhof,et al.  Scalp Psoriasis, Clinical Presentations and Therapeutic Management , 1998, Dermatology.

[5]  P. C. van de Kerkhof,et al.  Evaluation of Topical Drug Treatment in Psoriasis , 1998, Dermatology.

[6]  P. V. D. van de Kerkhof,et al.  A novel dithranol formulation (Micanol): the effects of monotherapy and UVB combination therapy on epidermal differentiation, proliferation and cutaneous inflammation in psoriasis vulgaris. , 1996, Acta dermato-venereologica.

[7]  J. Weiss,et al.  Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate-to-severe scalp psoriasis. , 1995, Clinical therapeutics.

[8]  O. Larko.  Problem sites: scalp, palm and sole, and nail. , 1995, Dermatologic clinics.

[9]  T. Reunala,et al.  Comparative effects of calcipotriol solution (50 μg/ml) and betamethasone 17‐valerate solution (1 mg/ml) in the treatment of scalp psoriasis , 1994 .

[10]  M. Rustin,et al.  Comparative effects of calcipotriol (MC903) solution and placebo (vehicle of MC903) in the treatment of psoriasis of the scalp , 1994, The British journal of dermatology.

[11]  T. Reunala,et al.  Comparative effects of calcipotriol solution (50 micrograms/ml) and betamethasone 17-valerate solution (1 mg/ml) in the treatment of scalp psoriasis. , 1994, The British journal of dermatology.

[12]  M. Lebwohl,et al.  A double-blind, vehicle-controlled study of clobetasol propionate 0.05% (Temovate) scalp application in the treatment of moderate to severe scalp psoriasis. , 1991, Journal of the American Academy of Dermatology.

[13]  D. Hoop,et al.  Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris , 1991, The Lancet.

[14]  E. Peets,et al.  Mometasone Furoate Lotion Once Daily Versus Triamcinolone Acetonide Lotion Twice Daily in Psoriasis , 1989, International journal of dermatology.

[15]  P. Harrison,et al.  Short contact dithranol therapy: advantages of a stiff emulsifying ointment base , 1989, The British journal of dermatology.

[16]  N. Lowe,et al.  The release and percutaneous permeation of anthralin products, using clinically involved and uninvolved psoriatic skin. , 1987, Journal of the American Academy of Dermatology.

[17]  B. Shroot.  [Anthralin]. , 2020, Annales de dermatologie et de venereologie.

[18]  S. Wright,et al.  Comparison of a cream containing 0 1% dithranol in a 17% urea base (Psoradrate®) with coal tar pomade in the treatment of scalp psoriasis , 1985, Clinical and experimental dermatology.

[19]  L. Kanerva,et al.  [Treatment of scalp psoriasis. A new dexamethasone preparation in a double-blind trial with hydrocortisone-17-butyrate]. , 1985, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis.

[20]  J. Roduner,et al.  [Dermovate scalp application in dermatology. A multi-centre Swiss study (author's transl)]. , 1980, Therapeutische Umschau. Revue therapeutique.

[21]  H. Meffert,et al.  [Dithranol therapy of common psoriasis of the scalp]. , 1979, Dermatologische Monatschrift.

[22]  A. Lassus.  Local treatment of psoriasis of the scalp with clobetasol propionate in alcoholic solution: a day application a comparison of once and twice , 1976 .

[23]  A. Lassus.  Local treatment of psoriasis of the scalp with clobetasol propionate in alcoholic solution: a comparison of once and twice a day application. , 1976, Current medical research and opinion.

[24]  H. Schaefer,et al.  Absolute concentrations of dithranol and triacetyl-dithranol in the skin layers after local treatment: in vivo investigations with four different types of pharmaceutical vehicles. , 1975, The Journal of investigative dermatology.

[25]  Hellier Ff.  Treatment of psoriasis of the scalp. , 1968 .